Artificial Intelligence in Cystic Fibrosis treatment and management

Cystic Fibrosis (CF) is a complex, chronic, multi- system, genetic disease. In the recent years many breakthrough therapies have been developed that have revolutionized management and totally changed the disease trajectory. Artificial intelligence is a rapidly evolving scientific field that can revolutionize chronic disease management including CF care. This review focuses on AI contribution in advancing CF therapeutics development, developing CF prediction models to better understand the disease natural course and individualizing treatment plans, including enabling patients to improve their self-monitoring and self-care. Additionally, the role of AI in the management of antimicrobial resistance and CF complications is explored.